Global Recombinant DNA Technology Industry (2020 to 2027) - Key Market Trends and Drivers

Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Recombinant DNA Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at a CAGR of 4.7% over the period 2020-2027.

Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $179.7 Million, While China is Forecast to Grow at 4.4% CAGR

The Recombinant DNA Technology market in the U.S. is estimated at US$179.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.5 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 32 Featured):

• Amgen Inc

• Bamboo Therapeutics, Inc.

• Biocon

• Biogen

• Chiron Corporation

• Cibus

• Eli Lilly and Company

• F. Hoffmann-La Roche Ltd

• Genentech, Inc

• GenScript

• GlaxoSmithKline plc.

• Horizon Discovery Group plc

• Merck KGaA

• Monsanto Company

• New England Biolabs

• Novartis AG

• Novo Nordisk A/S

• Nucelis

• Pfizer Inc.

• Profacgen

• Sanofi

• Syngene

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights

• World Market Trajectories

• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

• UNITED STATES

• CANADA

• JAPAN

• CHINA

• EUROPE

• FRANCE

• GERMANY

• ITALY

• UNITED KINGDOM

• REST OF EUROPE

• ASIA-PACIFIC

• REST OF WORLD

IV. COMPETITION

• Total Companies Profiled: 32

For more information about this report visit https://www.researchandmarkets.com/r/x9gndu

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900